Page 501 - Read Online
P. 501
Page 10 of 10 Zein et al. Plast Aesthet Res 2020;7:44 I http://dx.doi.org/10.20517/2347-9264.2020.133
54. Alijotas-Reig J, Fernandez-Figueras MT, Puig L. Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers.
Semin Arthritis Rheum 2013;43:241-58.
55. Dumitrascu DI, Georgescu AV. The management of biofilm formation after hyaluronic acid gel filler injections: a review. Clujul Med
2013;86:192-5.
56. Rohrich RJ, Bartlett EL, Dayan E. Practical approach and safety of hyaluronic acid fillers. Plast Reconstr Surg Glob Open 2019;7:e2172.
57. Bogdan Allemann I, Baumann L. Hyaluronic acid gel (Juvederm) preparations in the treatment of facial wrinkles and folds. Clin Interv
Aging 2008;3:629-34.
58. Lee W, Hwang SG, Oh W, Kim CY, Lee JL, et al. Practical guidelines for hyaluronic acid soft-tissue filler use in facial rejuvenation.
Dermatol Surg 2020;46:41-9.
59. Ballin AC, Cazzaniga A, Brandt FS. Long-term efficacy, safety and durability of Juvederm(R) XC. Clin Cosmet Investig Dermatol
2013;6:183-9.
60. Öhrlund Å. Evaluation of rheometry amplitude sweep cross-over point as an index of flexibility for ha fillers. J Cosmet Dermatol Sci
Appl 2018;8:47-54.
